Circulating resistin protein and mRNA concentrations and clinical severity of coronary artery disease

Jelena Joksic1, Miron Sopic1, Vesna Spasojevic-Kalimanovska1

  • 1Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.

Biochemia Medica
|June 26, 2015
PubMed

Insights

Plasma resistin is elevated in acute coronary syndrome (ACS) patients, correlating with disease severity. While resistin mRNA levels in peripheral blood mononuclear cells (PBMC) did not differ, both plasma resistin and PBMC resistin mRNA negatively correlated with HDL-C.

Area of Science:

  • Biochemistry
  • Cardiology
  • Molecular Biology

Background:

  • Previous research indicates a strong association between plasma resistin and coronary artery disease (CAD).
  • Understanding resistin's role in different clinical severities of CAD is crucial for targeted therapeutic strategies.

Purpose of the Study:

  • To investigate differences in plasma resistin protein and peripheral blood mononuclear cell (PBMC) resistin mRNA levels across varying clinical severities of CAD.
  • To explore correlations between resistin levels, HDL-C, and serum creatinine in CAD patients.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) for plasma resistin.
  • Real-time quantitative polymerase chain reaction (RT-qPCR) for PBMC resistin mRNA.
  • Comparative analysis between healthy controls (CG), CAD-negative patients, and CAD-positive patients (stable angina pectoris [SAP] and acute coronary syndrome [ACS]).

Main Results:

  • Plasma resistin was significantly higher in ACS patients compared to CG and CAD-negative groups.
  • Resistin mRNA expression in PBMCs did not significantly differ across groups but correlated positively with plasma resistin.
  • Both plasma resistin and PBMC resistin mRNA showed a negative correlation with HDL-C, and plasma resistin positively correlated with serum creatinine.

Conclusions:

  • Elevated plasma resistin is a marker for acute coronary syndrome (ACS).
  • A positive association exists between plasma resistin and resistin mRNA in PBMCs, despite unchanged mRNA levels across disease states.
  • Resistin levels are inversely related to HDL-C and directly related to serum creatinine, suggesting potential roles in CAD pathogenesis and progression.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
773
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
581
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
861
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
998
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
770